Life Mel won a special type of honey with extra antioxidants reduces side effects of chemotherapy, said Phase I study. Article updated July 14, 2011

January 9, 2008: Source: Med Oncol. 2006, 23 (4) :549-52

A special game called Life Mel honey in a study proves that the side effects of chemotherapy slows. This honey is now available in the Netherlands press release said Life Mel organization. We publish this press release with self-study found abstract heben continue unchanged but no link with this company. Please read our disclaimer .

Life Mel Honey inhibits chemotherapy side down.

Haarlem, January 8, 2007 - A medicinal honey, Life Mel, is capable of side effects of chemotherapy to combat, according to clinical research. The product is available in Israel for several years and appears now in the Netherlands market.

In cancer chemotherapy, the white blood cells rapidly degraded. This ensures that patients are susceptible to many infections. When using Life Mel, which appears to be inhibited degradation, allowing patients to better express their natural defenses to maintain. Also, they feel better during chemotherapy.

Life Mel is 100 percent natural and is produced by bees that have fed on a mixture of honey and medicinal herbs. Except for the preparation of the feed mixture for the bees, the collection of medicinal honey in the hive and packing, the man plays no role in the production process. After collecting the honey in the hive, no other ingredients added to Life Mel.

The manufacturer notes that Life Mel is not a medicine, but the product nevertheless clinically tested. The test was conducted in Israel by Prof. Gamal Zeidan, Head of Oncology at the Ziv Medical Center in Safed, Prof. Eitan Friedman of Sheba Medical Center and Dr. Moshe Stein of the Oncology Department at the Rambam Health Care Campus. The results were published in the medical journal Medical Oncology. The tests showed that Life Mel is both safe and effective.

There will soon start a phase 2 study involving sixty breast cancer patients participate. Half of the participants receive regular honey and half Life Mel. The researchers examine whether there is a big difference in blood counts in both patient groups.

Recommended in the morning to take a tablespoon of Life Mel and one tablespoon in the evening. For a higher dose can best seek medical attention. The manufacturer also advises diabetics and people who are allergic to honey to first contact their doctor before using Life Mel to proceed. More information about the product can be found at Lifemel.nl .

Here is the abstract of the study as we felt in PubMed

1: Med Oncol. 2006, 23 (4) :549-52. Left Prevention of chemotherapy-induced neutropenia by special honey intake.Zidan J, L Shetver, Gershuny A, Abzah A, Tamam S, Stein M, Friedman E. Oncology Unit, Sieff Hospital, Safed, Israel. zidan.j @ ziv.health.gov.il

Febrile neutropenia is a serious side effect of chemotherapy. Colony-stimulating factors (CSFs) are overused for primary and secondary treatment in patients with grade 4 neutropenia. The use of CSFs is expensive and accompanied by side effects. In the current study, Life-Mel Honey (LMH) was Administered to Prevent neutropenia and to reducing the need for CSFs in Patients Treated with chemotherapy. Thirty Cancer Patients Receiving chemotherapy for primary or meta-static disease were included. ALL patients had grade 4 neutropenia and were Treated with CSFs. The Patient The Same repeated chemotherapy schedule, with the addition under or LMH for 5 d. Blood count was ormed weekly. There was no recurrence of neutropenia after LMH intake and no need for treatment with CSFs in 12 (40%) or patients. Eighteen (60%) patients with grade 4 neutropenia LMH Developed and Were Treated with CSFs (p = 0.007). Hemoglobin levels remained> 11 g / dL consistently LMH intake in 19 (64%) patients. Only three (10%) patients had thrombocytopenia. Eight (32%) patients reported improvement in quality of life. The use of LMH in patients who are at high risk of neutropenia as a result of Developing chemotherapy decreases the risk of pancytopenia and the need for CSFs. LMH is inexpensive, has no side effects, and is easy to Administer.

PMID: 17303914 [PubMed - indexed for MEDLINE]